NO922313D0 - Piperidinforbindelser og en farmasoeytisk sammensetning - Google Patents

Piperidinforbindelser og en farmasoeytisk sammensetning

Info

Publication number
NO922313D0
NO922313D0 NO922313A NO922313A NO922313D0 NO 922313 D0 NO922313 D0 NO 922313D0 NO 922313 A NO922313 A NO 922313A NO 922313 A NO922313 A NO 922313A NO 922313 D0 NO922313 D0 NO 922313D0
Authority
NO
Norway
Prior art keywords
alkyl
hydrogen
compounds
piperide
pharmaceutical composition
Prior art date
Application number
NO922313A
Other languages
English (en)
Norwegian (no)
Other versions
NO922313L (no
Inventor
Palle Jakobsen
Ursula Sonnewald
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO922313D0 publication Critical patent/NO922313D0/no
Publication of NO922313L publication Critical patent/NO922313L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO92922313A 1989-12-18 1992-06-12 Piperidinforbindelser og en farmasoeytisk sammensetning NO922313L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK640289A DK640289D0 (da) 1989-12-18 1989-12-18 Ny heterocyklisk kemi
PCT/DK1990/000325 WO1991009032A1 (en) 1989-12-18 1990-12-11 Piperidine compounds and a pharmaceutical composition

Publications (2)

Publication Number Publication Date
NO922313D0 true NO922313D0 (no) 1992-06-12
NO922313L NO922313L (no) 1992-06-12

Family

ID=8148694

Family Applications (2)

Application Number Title Priority Date Filing Date
NO92922313A NO922313L (no) 1989-12-18 1992-06-12 Piperidinforbindelser og en farmasoeytisk sammensetning
NO1994003C NO1994003I1 (no) 1989-12-18 1994-07-01 Paroxetine/ (-)-trans-4-(4'-fluorophenyl)-3-((3',4'-methylenedioxyphenoxy)methyl)-piperidine

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO1994003C NO1994003I1 (no) 1989-12-18 1994-07-01 Paroxetine/ (-)-trans-4-(4'-fluorophenyl)-3-((3',4'-methylenedioxyphenoxy)methyl)-piperidine

Country Status (18)

Country Link
US (1) US5102894A (ja)
EP (1) EP0505465B1 (ja)
JP (1) JPH05502867A (ja)
CN (1) CN1052674A (ja)
AT (1) ATE135704T1 (ja)
AU (1) AU645722B2 (ja)
CA (1) CA2071480A1 (ja)
DE (1) DE69026110T2 (ja)
DK (2) DK640289D0 (ja)
ES (1) ES2084151T3 (ja)
FI (1) FI922826A (ja)
IE (1) IE904435A1 (ja)
IL (2) IL96592A0 (ja)
NO (2) NO922313L (ja)
PT (1) PT96235B (ja)
WO (1) WO1991009032A1 (ja)
ZA (1) ZA9010183B (ja)
ZW (1) ZW19190A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763589B1 (fr) * 1997-05-22 2001-01-05 Centre Nat Rech Scient Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention
AU9087301A (en) 2000-09-11 2002-03-26 Sepracor Inc Ligands for monoamine receptors and transporters, and methods of use thereof
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
US7531555B2 (en) 2003-10-01 2009-05-12 University Of Florida Research Foundation, Inc. Compositions and methods for selective inhibition of nicotine acetylcholine receptors
US8258305B2 (en) 2005-02-23 2012-09-04 Prexa Pharmaceuticals, Inc. Dopamine transporter inhibitors for use in treatment of movement disorders and other CNS indications
AU2006216651A1 (en) * 2005-02-23 2006-08-31 Prexa Pharmaceuticals, Inc. Multimediator dopamine transport inhibitors, and uses related thereto

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895965A (en) * 1959-07-21 Process for the production of
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
DK231088D0 (da) * 1988-04-28 1988-04-28 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
DK588289D0 (da) * 1989-11-22 1989-11-22 Ferrosan As Ny heterocyklisk kemi

Also Published As

Publication number Publication date
PT96235B (pt) 1998-06-30
PT96235A (pt) 1991-09-30
ZW19190A1 (en) 1991-06-05
ATE135704T1 (de) 1996-04-15
ES2084151T3 (es) 1996-05-01
IL96592A0 (en) 1991-09-16
FI922826A0 (fi) 1992-06-17
EP0505465B1 (en) 1996-03-20
IL96592A (en) 1995-06-29
DK640289D0 (da) 1989-12-18
AU6971691A (en) 1991-07-18
NO1994003I1 (no) 1994-07-01
CA2071480A1 (en) 1991-06-19
AU645722B2 (en) 1994-01-20
JPH05502867A (ja) 1993-05-20
DE69026110T2 (de) 1996-10-02
DE69026110D1 (de) 1996-04-25
IE904435A1 (en) 1991-06-19
DK0505465T3 (da) 1996-08-05
CN1052674A (zh) 1991-07-03
EP0505465A1 (en) 1992-09-30
NO922313L (no) 1992-06-12
WO1991009032A1 (en) 1991-06-27
ZA9010183B (en) 1991-10-30
US5102894A (en) 1992-04-07
FI922826A (fi) 1992-06-17

Similar Documents

Publication Publication Date Title
FI973895A (fi) 2-(3(S)-((L-asparaginyyli)amino)-2(R)-hydroksi-4-fenyylibutyyli)-N-tert-butyylidekahydro-(4aS,8aS)-isokinoliini-3(S)-karboksiamidijohdannaiset
FI940012A0 (fi) Aryylisulfonamidosubstituoidut hydroksaamihapot
DK0699191T3 (da) Sulfonamider og derivater deraf, der modulerer aktiviteten af endotelin
FI911330A (fi) 1,4,7,10-tetra-azacyklododekan -butyltrioler, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska aemnen.
DK147089D0 (da) Arylhydrazoner
ES2181853T3 (es) Tratamiento del tinnitus empleando agentes neuroprotectores.
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
NO922313L (no) Piperidinforbindelser og en farmasoeytisk sammensetning
DK630987D0 (da) Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
NO930830D0 (no) Nye beta-aminosyrederivater
DK592688D0 (da) Benz(thi)amidderivater, deres fremstilling og anvendelse som fungicider
DK0610078T3 (da) Cytotoksisk og antiviral forbindelse.
GR3019893T3 (en) Novel S-adenosyl methionine decarboxylase inhibitors
DE3575925D1 (de) Kristalline form von benzothiazindioxydsalz.
DK102084D0 (da) N-(3-trifluormethylphenyl)-n'-propargylpiperazin, dets fremstilling og anvendelse
ES554830A0 (es) Procedimiento para preparar derivados de 1,3-oxatiano
PT784973E (pt) Derivados de quinoxalina para o tratamento de zumbido nos ouvidos
DK0743300T3 (da) 15-deoxyspergualin-beslægtede forbindelser, fremgangsmåde til deres fremstilling og deres anvendelse i terapi
ATE140222T1 (de) 4-heteroaryl-piperidin-zwischenprodukte und deren herstellung
IT1191617B (it) Propionilanilidi farmacologicamente attive